Objectives: This study sought to investigate the safety and efficacy of transcatheter treatment
of atrial septal aneurysm (ASA) associated with patent foramen ovale (PFO). Background …

Background: The association between patent foramen ovale (PFO), atrial septal aneurysm,
and cryptogenic stroke due to paradoxical embolism has been established. The correlation …

Background—Patients with a patent foramen ovale (PFO) and paradoxical embolism are at
risk for recurrent thromboembolic events. This study investigated the long-term risk of …

Objective To review our experience with, and profile the safety and efficacy of, the Amplatzer
PFO (patent foramen ovale) occluder (APO) and Amplatzer septal occluder (ASO) used to …

BACKGROUND: Optimal management of patients with PFO and paradoxical embolic events
is still debated. Moreover, data from long-term studies on large patient populations are …

The purpose of this study was to assess the safety and feasibility of percutaneous
interventional closure of patent foramen ovale (PFO) with or without atrial septal aneurysm …

OBJECTIVES We report the largest and the longest follow-up to date of patients who
underwent transcatheter patent foramen ovale (PFO) closure for paradoxical embolism …

We investigated the efficacy of transcatheter patent foramen ovale (PFO) closure to prevent
recurrent cerebral ischemic events in patients who did and those who did not have …

Background In patients with patent foramen ovale (PFO)–associated stroke, the presence of
large shunt or atrial septal aneurysm (ASA) has been suggested to convey a high risk of …

Objectives: We postulate that, in patients with large patent foramen ovales (PFO) and atrial
septal aneurysms (ASA), left atrial (LA) dysfunction simulating “atrial fibrillation (AF)-like” …